Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Wyeth Pharmaceuticals in $40m Indian deal

Wyeth Pharmaceuticals in $40m Indian deal

17th January 2006

Wyeth Pharmaceuticals has struck an outsourcing deal with Indian firm GVK Biosciences.

The deal is believed to be worth around $40 million, although exact financial details have not been released, and will see GVK Bio providing a range of services in synthetic chemistry research.

The company will also employ 150 chemists to work exclusively on Wyeth projects.

Frank Walsh, Wyeth executive vice president and head of discovery research, explained the company choose GVK Bio because of the growing skills base in the area with India’s recent adoption of patent laws that meet World Trade Organisation provisions.

Sanjay Reddy, GVK Bio chief executive, said: “This alliance would become a trendsetter in the way contract research business is carried out in India, and pave way for many international companies to look at long-term contracts with Indian CROs [contract research organisations].

“We are absolutely delighted by this development and the confidence that Wyeth Pharmaceuticals has reposed in the scientific talent and execution capabilities of GVK Bio.”

track© Adfero Ltd

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.